Fast Market Research

Bayer AG - Product Pipeline Review - 2012 - New Market Research Report

Recently published research from Global Markets Direct, "Bayer AG - Product Pipeline Review - 2012", is now available at Fast Market Research


Boston, MA -- (SBWIRE) -- 11/29/2012 -- Global Market Direct's pharmaceuticals report, "Bayer AG - Product Pipeline Review - 2012" provides data on the Bayer AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Bayer AG's corporate website, SEC filings, investor presentations and featured press releases, both from Bayer AG and industry-specific third party sources, put together by Global Markets Direct's team.


- Bayer AG - Brief Bayer AG overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Bayer AG human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Bayer AG with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Bayer AG's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get this Report

- Evaluate Bayer AG's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Bayer AG in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Bayer AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Bayer AG.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Bayer AG and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Bayer AG - Product Pipeline Review - H2 2011
- Wilex AG - Product Pipeline Review - 2012
- Renal Cell Carcinoma - Pipeline Review, H1 2012
- Hepatocellular Carcinoma - Pipeline Review, H1 2012
- 4SC AG - Product Pipeline Review - 2012
- Stroke - Pipeline Review, H1 2012
- Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2012
- Pieris AG - Product Pipeline Review - 2012
- MediGene AG - Product Pipeline Review - 2012
- Affimed Therapeutics AG - Product Pipeline Review - 2012